| Keryx Biopharmaceuticals' Phase 2 Data of KRX-0401 (Perifosine) in ... - Reuters |
|
|
ReutersAbout Renal Cell Carcinoma (RCC) Of all kidney tumors, 85% are classified as renal cell carcinoma (RCC) and of all patients with RCC, 25% present with ... read more |